Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition
Molecular Endocrinology · 01.02.2016 · 30 (2) · 201-216
DOI: 10.1210/me.2015-1194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Endocrinology, erschienen am 01.02.2016. Verfasst von Ian Damerill und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry (I.D., K.K.B., S.S.-C.L., M.B.G.), University of Western Ontario, London, Ontario, N6C 2V5 Canada; Department of Obstetric…. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
In fetal growth restriction (FGR), fetal growth is limited by reduced nutrient and oxygen supply. Insulin-like growth factor I (IGF-I) is a key regulator of fetal growth and IGF binding protein -1(IGFBP-1) is the principal regulator of fetal IGF-I bioavailability. Phosphorylation enhances IGFBP-1's affinity for IGF-I. Hypoxia induces IGFBP-1 hyperphosphorylation, markedly decreasing IGF-I bioavailability. We recently reported that fetal liver IGFBP-1 hyperphosphorylation is associated with inhibition of the mechanistic target of rapamycin (mTOR) in a nonhuman primate model of FGR. Here, we test the hypothesis that IGFBP-1 hyperphosphorylation in response to hypoxia is mediated by mTOR inhibition. We inhibited mTOR either by rapamycin or small interfering RNA (siRNA) targeting raptor (mTOR complex [mTORC]1) and/or rictor (mTORC2) in HepG2 cells cultured under hypoxia (1% O2) or basal (20% O2) conditions. Conversely, we activated mTORC1 or mTORC1+mTORC2 by silencing endogenous mTOR inhibitors (tuberous sclerosis complex 2/DEP-domain-containing and mTOR-interacting protein). Immunoblot analysis demonstrated that both hypoxia and inhibition of mTORC1 and/or mTORC2 induced similar degrees of IGFBP-1 phosphorylation at Ser101/119/169 and reduced IGF-I receptor autophosphorylation. Activation of mTORC1+mTORC2 or mTORC1 alone prevented IGFBP-1 hyperphosphorylation in response to hypoxia. Multiple reaction monitoring-mass spectrometry showed that rapamycin and/or hypoxia increased phosphorylation also at Ser98 and at a novel site Ser174. In silico structural analysis indicated that Ser174 was in close proximity to the IGF-binding site. Together, we demonstrate that signaling through the mTORC1 or mTORC2 pathway is sufficient to induce IGFBP-1 hyperphosphorylation in response to hypoxia. This study provides novel understanding of the cellular mechanism that controls fetal IGFBP-1 phosphorylation in hypoxia, and we propose that mTOR inhibition constitutes a mechanistic link between hypoxia, reduced IGF-I bioavailability and FGR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry (I.D., K.K.B., S.S.-C.L., M.B.G.), University of Western Ontario, London, Ontario, N6C 2V5 Canada; Department of Obstetrics and Gynecology (T.J.), University of Colorado Anschutz Medical Campu…
Förderung
- NICHD NIH HHS
Zitieren
APA
Damerill, I., Biggar, K. K., Abu Shehab, M., Li, S. S., Jansson, T., & Gupta, M. B. (2016). Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition. Molecular Endocrinology, 30(2), 201-216. https://doi.org/10.1210/me.2015-1194
Vancouver
Damerill I, Biggar KK, Abu Shehab M, Li SS, Jansson T, Gupta MB. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition. Molecular Endocrinology. 2016;30(2):201-216. doi:10.1210/me.2015-1194
BibTeX
@article{Damerill2016,
author = {Damerill, Ian and Biggar, Kyle K and Abu Shehab, Majida and Li, Shawn Shun-Cheng and Jansson, Thomas and Gupta, Madhulika B},
title = {Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition},
journal = {Molecular Endocrinology},
year = {2016},
volume = {30},
number = {2},
pages = {201--216},
doi = {10.1210/me.2015-1194}
}
EUVIMED